The Global Triclabendazole API Market was valued at USD 146.8 Million in 2024 and is projected to reach USD 245.6 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period (2024–2032). This growth is being driven by increasing prevalence of parasitic infections, rising livestock populations, and growing awareness about neglected tropical diseases across developing regions.
As healthcare systems worldwide strengthen their focus on parasitic disease control and veterinary health initiatives, pharmaceutical companies are ramping up production of this critical anthelmintic API. In this blog, we profile the Top 10 Companies in the Triclabendazole API Industry—a mix of established manufacturers and emerging players shaping the global supply of this essential medicine for treating fascioliasis in both humans and animals.
🔟 1. Hunan Huateng Pharmaceutical Co., Ltd.
Headquarters: Changsha, Hunan, China
Key Offering: High-purity Triclabendazole API (≥99%), Custom Synthesis Services
Hunan Huateng Pharmaceutical is the global market leader in Triclabendazole API production, holding an estimated 18% market share in 2024. The company operates WHO-GMP certified manufacturing facilities with extensive quality control systems, making it the preferred supplier for generic drug manufacturers across South America and Southeast Asia.
Manufacturing Capabilities:
-
Vertically integrated production from key intermediates
-
Annual production capacity exceeding 80 metric tons
-
Vertically integrated production from key intermediates
Download FREE Sample Report: Triclabendazole API Market – View in Detailed Research Report
9️⃣ 2. Ipca Laboratories Ltd.
Headquarters: Mumbai, Maharashtra, India
Key Offering: USP/EP grade Triclabendazole API, Veterinary formulations
Ipca Laboratories has emerged as a leading global supplier of Triclabendazole API following its strategic alliance with Medicines for Malaria Venture. The company supplies over 120 countries with pharmaceutical-grade API for both human and veterinary applications.
Manufacturing Capabilities:
-
FDA-approved manufacturing facilities
-
Integrated quality management systems
8️⃣ 3. Hebei Veyong Pharmaceutical Co., Ltd.
Headquarters: Shijiazhuang, Hebei, China
Key Offering: ≥99% purity Triclabendazole API, Technical grade material
Hebei Veyong Pharmaceutical specializes in high-purity benzimidazole derivatives, supplying multiple global markets including Europe and North America.
Manufacturing Capabilities:
-
Advanced purification technologies
-
R&D focus on novel synthesis routes
7️⃣ 4. Alivira Animal Health Limited
Headquarters: Mumbai, Maharashtra, India
Key Offering: Veterinary-grade Triclabendazole API, Custom formulations
Alivira Animal Health, a joint venture between Virbac and two Indian pharmaceutical companies, has become a significant player in the API market following its FDA facility approval in 2024.
Manufacturing Capabilities:
-
Specialized veterinary API production
-
Cephalal to-tail production optimization
Download FREE Sample Report: Triclabendazole API Market – View in Detailed Research Report
6️⃣ 5. Rakshit Drugs Pvt. Ltd.
Headquarters: Mumbai, Maharashtra, India
Key Offering: Pharmaceutical-grade Triclabendazole API, Contract manufacturing
Rakshit Drugs has established itself as a reliable supplier of Triclabendazole API to domestic and international markets.
Manufacturing Capabilities:
-
Focus on cost-competitive production
-
Extensive export network across Africa and Latin America.
Manufacturing Capabilities:
-
Batch processing capabilities
-
Custom particle size distribution
5️⃣ 6. Nuray Chemicals
Headquarters: Izmir, Turkey
Key Offering: Triclabendazole API, Intermediate chemicalsNuray Chemicals serves as a key regional supplier of Triclabendazole API to Middle Eastern and European markets.
Manufacturing Capabilities:
-
Strategic geographic positioning
-
Quality management systems compliant with Turkish Medicines and Medical Devices Agency requirements.
Manufacturing Capabilities:
-
Compliance with EU GMP standards
4️⃣ 7. Bazayan & Co.
Headquarters: Amman, Jordan
Key Offering: Pharmaceutical-grade API, Custom manufacturingBazayan & Co. has strengthened its market position through its joint venture with Tabuk Pharmaceuticals.
Manufacturing Capabilities:
-
Middle East and North Africa market specialization
-
Regional distribution partnerships
3️⃣ 8. Omgene Life Sciences
Headquarters: Hyderabad, Telangana, India
Key Offering: High-purity Triclabendazole API, Research chemicalsOmgene Life Sciences has become the preferred supplier for 7 out of 10 Indian generic manufacturers through competitive pricing and reliable supply chain management.
Manufacturing Capabilities:
-
Continuous process improvement
-
Focus on meeting stringent quality standards
2️⃣ 9. PROCYON LIFE SCIENCES
Headquarters: Mumbai, Maharashtra, India
Key Offering: Pharmaceutical-grade Triclabendazole API, Custom synthesisPROCYON LIFE SCIENCES leverages its proprietary continuous flow manufacturing technology to achieve a 40% production cost advantage over traditional batch processing competitors.
Manufacturing Capabilities:
-
Advanced process automation
-
Specialized purification expertise
1️⃣ 10. Tenatra Chemie
Headquarters: Vadodara, Gujarat, India
Key Offering: Standard and custom purity grades, Research quantitiesTenatra Chemie has established a niche position by supplying smaller batches to research institutions and specialized pharmaceutical companies.
Manufacturing Capabilities:
-
Flexible production scale capabilities
-
Flexible manufacturing approach
Get Full Report Here: Triclabendazole API Market – View in Detailed Research Report
These pharmaceutical companies are not only supplying critical anthelmintic treatments—they’re advancing global health initiatives against neglected tropical diseases.
🌍 Outlook: The Future of Triclabendazole API is Strategic and Sustainable
The triclabendazole API market is undergoing significant transformation as manufacturers balance traditional production methods with emerging sustainable practices to meet growing global healthcare demands.
📈 Key Trends Shaping the Market:
-
Increasing strategic partnerships between API producers and formulation manufacturers
-
Expansion of production capacities in emerging markets
-
Development of high-purity formulations for specialized applications
-
Growing emphasis on green chemistry principles in API manufacturing
Get Full Report Here: Triclabendazole API Market – View in Detailed Research Report
The companies listed above are not only manufacturing essential medicines—they’re expanding access to parasitic disease treatments worldwide.
Latest posts by Rohit k (see all)- Top 10 Companies in the Butyric Anhydride Market (2025): Global Leaders Powering Flavor, Fragrance, and Specialty Chemicals - October 28, 2025
- Top 10 Companies in the Ferrite Magnets Industry (2025): Market Leaders Powering Global Electronics - October 28, 2025
- Top 10 Companies in the North America Flucythrinate Market (2025): Key Players Driving Crop Protection Innovation - October 28, 2025
-
-
